Welcome Siv Jönsson!

It is with great pleasure that we welcome Siv Jönsson to our team! Siv has been working in the pharmacokinetic, pharmacodynamic and pharmacometric areas in the pharmaceutical industry for a total of 5 years (Kabi Pharmacia, AstraZeneca), as a regulatory assessor at the Swedish Medical Products Agency for 9 years, and spent +10 years in academia as a senior lecturer and researcher dealing with methodological and applied pharmacometric projects. She will retain a part time affiliation as a senior researcher in the Pharmacometrics Research Group, Uppsala University. See her bio here.

Continue Reading

Welcome Ola Caster!

We are happy to welcome Ola Caster in our growing enabler team. Ola comes most recently from a position as a Senior Researcher at the Uppsala Monitoring Centre, where he worked primarily with methods for adverse effect detection and benefit-risk assessment in the post-marketing setting. He has more than ten years of experience from research in statistics and data science, including a PhD in Computer and Systems Sciences. See Ola's bio here.

Continue Reading

ACoP in Orlando

Come meet us at ACoP in Orlando next week. Drop by our booth to discuss model informed drug development with our experts and leaders. There are still opportunities for free speed consulting, should you want input to your strategic or hands-on work.

Continue Reading

Speed consulting at ACop 2019

This year, during the ACOP Meeting in Orlando, Pharmetheus will offer professional pharmacometric consulting sessions (~30 min), free of charge. Talk to us about Pharmacometrics, PBPK, Regulatory strategy, MIDD strategy, and much more! These sessions are open to everyone and independent of any current or future plans to use our services.

Continue Reading

Welcome Ari Brekkan and Antonio Klaric!

Pharmetheus continues to grow and we are very happy to announce the arrival of two new team members, Ari Brekkan, MIDD consultant, and Antonio Klaric, System administrator. Ari recently defended his PhD thesis at Uppsala University. His work focused on the application and use of pharmacometric models in the development of biological medicinal products. Antonio has experience in a variety

Continue Reading